Opendata, web and dolomites

FutForm SIGNED

Future Formulations: Developing Future Pharmaceuticals Through Advanced Analysis and Intersectoral Exchange

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "FutForm" data sheet

The following table provides information about the project.

Coordinator
THE UNIVERSITY OF NOTTINGHAM 

Organization address
address: University Park
city: NOTTINGHAM
postcode: NG7 2RD
website: www.nottingham.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.nottingham.ac.uk/futformrise/
 Total cost 414˙000 €
 EC max contribution 414˙000 € (100%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2015
 Funding Scheme MSCA-RISE
 Starting year 2016
 Duration (year-month-day) from 2016-04-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THE UNIVERSITY OF NOTTINGHAM UK (NOTTINGHAM) coordinator 297˙000.00
2    HY2CARE BV NL (ENSCHEDE) participant 54˙000.00
3    INOVAPOTEK, PHARMACEUTICAL RESEARCH AND DEVELOPMENT LDA PT (PORTO) participant 36˙000.00
4    ABIEL SOCIETA A RESPONSABILITA LIMITATA IT (PALERMO) participant 27˙000.00

Map

 Project objective

The estimated cost of getting a new medicine to market is now in excess of $2.6 billion, with an additional $300 million (approx.) typically being directed towards post market approval research and development activities (including testing of new indications, new formulations and new dosage strengths and regimens) (Nature Reviews Drug Discovery 13, 877 (2014)). These costs have increased >145% since 2003, and reflect an increasingly complex process in which there remains a high chance of failure in the expensive later phases of development. With the aim of reducing the times and costs associated with medicine development, increasing attention has focused on the development of approaches to better predict and/or optimize the behaviour of actives and their formulations at an earlier stage of development. Recent research within the School of Pharmacy (University of Nottingham (UoN)) has focussed on the application of advanced surface analytical and biophysical tools to address this need. This proposal will build on this activity via an intersectoral researcher exchange program focussed on supporting future pharmaceutical formulations development. The principal objective of FutForm is to translate the advanced analytical approaches developed within UoN, so that they become embedded into industrial practice for the development of future pharmaceutical processes and therapies. This will be achieved through a collaborative programme of researcher secondments with three small-medium enterprise (SME) companies, each with early stage innovative technologies in areas of importance to the future pharmaceutical industry, namely; enzyme formulations for improved cell isolation (Abiel s.r.l; Italy), nanoparticle platform formulations for oral and topical drug delivery (Inovapotek, Pharmaceutical Research and Development Lda; Portugal) and hydrogel formulations for cell-delivery (Hy2Care b.v.; Netherlands).

 Deliverables

List of deliverables.
Standardized SOPs for the optimized isolation of different cell types Documents, reports 2020-01-29 12:07:31
Generation of ISO 1345 Quality Management System Documents, reports 2020-01-29 12:07:30
Standardized protocols for the formulation of nanoparticles with defined properties Documents, reports 2020-01-29 12:07:31
FutForm Website up and running Websites, patent fillings, videos etc. 2020-01-29 12:07:30
Consortium agreement signed Other 2020-01-29 12:07:30

Take a look to the deliverables list in detail:  detailed list of FutForm deliverables.

 Publications

year authors and title journal last update
List of publications.
2018 Elaheh Jooybar, Mohammad J. Abdekhodaie, Mansour Alvi, Abbas Mousavi, Marcel Karperien, Pieter J. Dijkstra
An injectable platelet lysate-hyaluronic acid hydrogel supports cellular activities and induces chondrogenesis of encapsulated mesenchymal stem cells
published pages: , ISSN: 1742-7061, DOI: 10.1016/j.actbio.2018.10.031
Acta Biomaterialia 2020-01-29
2018 Simona Campora, Paola Sanjuan Alberte, Carmelo Bruno, Giulio Ghersi
Isolation of Adult Rat Cardiomyocytes Using Recombinant Collagenases
published pages: , ISSN: 2283-9216, DOI: 10.3303/CET1864005
CHEMICAL ENGINEERING TRANSACTIONS 2020-01-29

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FUTFORM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FUTFORM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

CONMECH (2019)

Nonsmooth Contact Dynamics

Read More  

ENDORSE (2018)

Safe, Efficient and Integrated Indoor Robotic Fleet for Logistic Applications in Healthcare and Commercial Spaces

Read More  

VIDEC (2020)

Visualizing Death Inducing Protein Complexes

Read More